4,080.00
-20.00
(-0.49%)
At close: 3:30:30 PM GMT+9
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in KRW | 3/31/2023 | 9/30/2023 |
|---|---|---|
| EPS Est. | -- | -- |
| EPS Actual | -47 | -78 |
| Difference | -- | -- |
| Surprise % | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 048530.KQ | -- | -- | -- | -- |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Related Tickers
078160.KQ MEDIPOST Co., Ltd.
8,650.00
+3.97%
298380.KQ ABL Bio Inc.
64,900.00
+2.53%
ARMP Armata Pharmaceuticals, Inc.
1.2300
+4.24%
PHGE BiomX Inc.
0.5397
-0.11%
VERV Verve Therapeutics, Inc.
4.5900
+1.77%
PRME Prime Medicine, Inc.
1.2400
0.00%
BEAM Beam Therapeutics Inc.
17.00
+2.29%
NTLA Intellia Therapeutics, Inc.
7.23
+5.39%
EDIT Editas Medicine, Inc.
1.2800
+0.79%
CRSP CRISPR Therapeutics AG
37.77
-0.03%